Trisenox and hyperglycaemia Patient Reports February 13, 2012

Trisenox Side Effects Report #4747951-6
Trisenox side effect was reported by a Health Professional from UNITED STATES on Aug 05, 2005. Female patient, 62 years of age, was diagnosed with multiple myeloma  and was treated with Trisenox. After drug was administered, patient experienced the following side effects: condition aggravated, hyperglycaemia, hypertension, neuropathy peripheral, tremor. Trisenox dosage: (14 MG, QD), IVI. During the same period patient was treated with MELPHALAN, ASCORBIC ACID, DEXAMETHASONE, KYTRIL, MIACALCIN, CALCIUM GLUCONATE, AREDIA, ZOMETA. Patient recovered.

Trisenox Side Effects Report #5768221-3
Trisenox side effect was reported by a Physician from JAPAN on May 26, 2008. Male patient, 85 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, diarrhoea, electrocardiogram qt prolonged, hepatic function abnormal, hyperglycaemia, leukocytosis, pleural effusion, pneumonia . Trisenox dosage: 8.4 MG DAILY INTRAVENOUS. During the same period patient was treated with GABAXATE MESILATE. Patient recovered.

Trisenox Side Effects Report #6073095-X
Trisenox side effect was reported by a Physician from JAPAN on Jan 28, 2009. Male patient, 85 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, alanine aminotransferase increased, blood lactate dehydrogenase increased, diarrhoea, electrocardiogram qt prolonged, gamma-glutamyltransferase increased, hyperglycaemia, leukocytosis, leukopenia. Trisenox dosage: 8.4 MG DAILY INTRAVENOUS. During the same period patient was treated with GABEXATE MESILATE. Patient recovered.

Trisenox Side Effects Report #5325380-4
Trisenox side effect was reported by a Physician from JAPAN on Apr 26, 2007. Female patient, 73 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: altered state of consciousness, blood bilirubin increased, cerebral haemorrhage, condition aggravated, dialysis , disseminated intravascular coagulation, hyperglycaemia, leukocytosis, pulmonary haemorrhage. Trisenox dosage: 7.62 MG QD INTRAVENOUS DRIP. During the same period patient was treated with ETOPOSIDE, TEICOPLANIN, NAFAMOSTAT MESILATE, MICONAZOLE, HYDROCORTISONE SUCCINATE, FAMOTIDINE. Patient died on 11/09/2005.


Trisenox Side Effects Report #5248065-1
Trisenox side effect was reported by a Physician from JAPAN on Feb 06, 2007. Male patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, catheter related infection, electrocardiogram qt prolonged, gamma-glutamyltransferase increased, hyperglycaemia, pathogen resistance, staphylococcal infection . Trisenox dosage: 9.69 MG Q1D INTRAVENOUS DRIP. During the same period patient was treated with DALTEPARIN, METHYLPHENIDATE, ALPRAZOLAM, MILNACIPRAN HYDROCHLORIDE, AMIKACIN SULPHATE, PAROXETINE HYDROCHLORIDE. Patient recovered.

Trisenox Side Effects Report #5306139-0
Trisenox side effect was reported by a Physician from JAPAN on Apr 02, 2007. Male patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, cardio-respiratory arrest, electrocardiogram qt prolonged, febrile neutropenia, gamma-glutamyltransferase increased, hyperglycaemia, staphylococcal sepsis. Trisenox dosage: 9.69 MG QD INTRAVENOUS DRIP. During the same period patient was treated with DALTEPARIN, QUETIAPINE FUMARATE, VANCOMYCIN HYDROCHLORIDE, CEFEPIME DIHYDROCHLORIDE, METHYLPHENIDATE, PAROXETINE. Patient died on 01/19/2006.

Trisenox Side Effects Report #5390810-9
Trisenox side effect was reported by a Physician from JAPAN on July 06, 2007. Male patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, catheter related infection, electrocardiogram qt prolonged, gamma-glutamyltransferase increased, hyperglycaemia, staphylococcal infection . Trisenox dosage: 9.69 MG QD INTRAVENOUS DRIP. During the same period patient was treated with DALTEPARIN, METHYLPHENIDATE, ALPRAZOLAM, MILNACIPRAN HYDROCHLORIDE, AMIKACIN SULPHATE, PAROXETINE HYDROCHLORIDE HYDRATE. Patient recovered.

Trisenox Side Effects Report #5393083-6
Trisenox side effect was reported by a Physician from JAPAN on June 27, 2007. Male patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood lactate dehydrogenase increased, cardio-respiratory arrest, electrocardiogram qt prolonged, febrile neutropenia, gamma-glutamyltransferase increased, hyperglycaemia, staphylococcal sepsis. Trisenox dosage: 9.69 MG QD INTRAVENOUS DRIP. During the same period patient was treated with DALTEPARIN, QUETIAPINE FUMARATE, VANCOMYCIN HYDROCHLORIDE, CEFEPIME DIHYDROCHLORIDE, METHYLPHENIDATE, PAROXETINE HYDROCHLORIDE HYDRATE. Patient died on 01/19/2006.

Trisenox Side Effects Report #5084861-1
Trisenox side effect was reported by a Physician from JAPAN on Aug 01, 2006. Male patient, 58 years of age, weighting 132.3 lb, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, disseminated intravascular coagulation, hyperglycaemia, oliguria, weight increased. Trisenox dosage: 9 MG QD INTRAVENOUS DRIP. During the same period patient was treated with GABEXATE MESILATE, DANAPAROID, FUROSEMIDE. Patient was hospitalized. Patient died on 05/16/2006.


Trisenox Side Effects Report #5125019-7
Trisenox side effect was reported by a Physician from JAPAN on Sept 22, 2006. Male patient, 58 years of age, weighting 132.3 lb, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood bilirubin increased, cerebral haemorrhage, condition aggravated, disseminated intravascular coagulation, hepatic function abnormal, hypercalcaemia, hyperglycaemia, hyponatraemia. Trisenox dosage: 9 MG QD INTRAVENOUS DRIP. During the same period patient was treated with GABEXATE MESILATE, DANAPAROID, FUROSEMIDE, VORICONAZOLE, SULFAMETHOXAZOLE. Patient was hospitalized. Patient died on 05/16/2006.

Trisenox Side Effects Report #5197209-9
Trisenox side effect was reported by a Physician from JAPAN on Dec 12, 2006. Male patient, 58 years of age, weighting 132.3 lb, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, condition aggravated, disseminated intravascular coagulation, febrile neutropenia, fungal infection , hypercalcaemia, hyperglycaemia, hyponatraemia, oliguria. Trisenox dosage: 9 MG QD INTRAVENOUS DRIP. During the same period patient was treated with GABEXATE MESILATE, DANAPAROID, FUROSEMIDE, VORICONAZOLE, SULFAMETHOXAZOLE. Patient was hospitalized. Patient died on 05/16/2006.

Trisenox Side Effects Report #5401990-0
Trisenox side effect was reported by a Physician from JAPAN on July 10, 2007. Female patient, 58 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, back pain , bone pain, disseminated intravascular coagulation, electrocardiogram qt prolonged, hypercalcaemia, hyperglycaemia, hyperkalaemia. Trisenox dosage: 7.5 MG QD INTRAVENOUS DRIP. During the same period patient was treated with IDARUBICIN, NAFAMOSTAT MESILATE, GLUCOSE W, ELECTROLYTE, PARENTERAL FLUID OF HIGH, INSULIN. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5483251-7
Trisenox side effect was reported by a Physician from JAPAN on Sept 27, 2007. Female patient, 58 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, alanine aminotransferase increased, blood creatine phosphokinase increased, haemolysis, hepatic function abnormal, hyperglycaemia, renal impairment, retinoic acid syndrome. Trisenox dosage: 8.85 MG QD INTRAVENOUS DRIP. During the same period patient was treated with IDARUBICIN, POTASSIUM SUPPLEMENT, GABEXATE MESILATE, CARPERITIDE, MICAFUNGIN. Patient recovered.

Trisenox Side Effects Report #5047199-4
Trisenox side effect was reported by a Physician from JAPAN on June 23, 2006. Male patient, 54 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: c-reactive protein increased, hyperglycaemia, pyrexia. Trisenox dosage: 12 MG QD INTRAVENOUS DRIP. During the same period patient was treated with PREDNISOLONE, METHYLPREDNISOLONE, DALTEPARIN, MICAFUNGIN, ACYCLOVIR, AMIKACIN SULPHATE, TAZOBACTAM PIPERACILLIN, CEFTAZIDIME. Patient was hospitalized. Patient recovered.


Trisenox Side Effects Report #4701607-4
Trisenox side effect was reported by a Physician from on June 07, 2005. Female patient, 54 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood alkaline phosphatase increased, blood urea decreased, electrocardiogram qt prolonged, hyperglycaemia, pancytopenia, protein total decreased. Trisenox dosage: 5.67 MG (5.67 MG, QD), IVI. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5022419-0
Trisenox side effect was reported by a Consumer or non-health professional from JAPAN on May 25, 2006. Male patient, 54 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: c-reactive protein increased, hyperglycaemia. Trisenox dosage: 12 MG QD INTRAVENOUS DRIP. During the same period patient was treated with PREDNISOLONE, METHYLPREDNISOLONE, DALTEPARIN, MICAFUNGIN, ACYCLOVIR, AMIKACIN SULPHATE, TEZOBACTAM PIPERACILLIN, CEFTAZIDIME. Patient recovered.

Trisenox Side Effects Report #5642186-7
Trisenox side effect was reported by a Health Professional from UNITED STATES on Feb 12, 2008. Female patient, child 5 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, anorexia, hyperglycaemia, neuralgia, pneumonitis. Trisenox dosage: 0.15 MG/KG INTRAVENOUS DRIP. Patient recovered.

Trisenox Side Effects Report #5913581-3
Trisenox side effect was reported by a Physician from JAPAN on Sept 24, 2008. Female patient, 43 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, electrocardiogram qt prolonged, hepatic function abnormal, hyperglycaemia, ventricular extrasystoles, white blood cell count decreased. Trisenox dosage: 10.2 MG QD INTRAVENOUS DRIP. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5817327-9
Trisenox side effect was reported by a Physician from JAPAN on July 01, 2008. Male patient, 42 years of age, weighting 133.8 lb, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, alanine aminotransferase increased, blood potassium decreased, blood sodium decreased, hepatic function abnormal, hyperglycaemia, hyperuricaemia, hypoalbuminaemia, hypoproteinaemia. Trisenox dosage: 8.7 MG DAILY; INTRAVENOUS DRIP. During the same period patient was treated with IDARUBICIN HYDROCHLORIDE, LANSOPRAZOLE, ITRACONAZOLE. Patient recovered.


Trisenox Side Effects Report #5933636-7
Trisenox side effect was reported by a Physician from JAPAN on Oct 16, 2008. Male patient, 42 years of age, weighting 133.8 lb, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, cardiomegaly, gamma-glutamyltransferase increased, hyperglycaemia, hyperuricaemia, hypoalbuminaemia. Trisenox dosage: 8.7 MG QD INTRAVENOUS DRIP. During the same period patient was treated with DEXAMETHASONE PHOSPHATE, DEXAMETHASONE PHOSPHATE, DEXAMETHASONE PHOSPHATE, IDARUBICIN HYDROCHLORIDE, LANSOPRAZOLE, ITRACONAZOLE. Patient recovered.